Skip to content
Review Open access

Compound heterozygous and digenic inheritance in early-onset Parkinson’s disease: a systematic review

Oct 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 43 references

TL;DR

These findings support comprehensive detection of structural and sequence variants while highlighting the need for segregation, functional, and replication evidence to distinguish causal DI from modifier effects or coincidental variant co-occurrence.

Abstract

Compound heterozygous (CH) genotypes represent an established biallelic autosomal-recessive mechanism in early-onset Parkinson’s disease (EOPD), whereas digenic inheritance (DI) has been proposed for variant combinations across two genes but is more difficult to establish. We systematically evaluated the genetic architecture and clinical features of CH cases and cases reported as DI in the published literature. This PRISMA-compliant systematic review included studies reporting CH or DI EOPD through September 2026. Two reviewers independently screened studies, extracted data, and curated variant- and case-level information. Variants were harmonized using current Human Genome Variation Society nomenclature and classified by gene, variant type, ancestry, and inheritance model. We included 106 studies comprising 304 CH and 16 DI cases. CH was dominated by PRKN , with structural variants present in 85% (205/241) of PRKN cases, predominantly exon-level deletions. PINK1 was the second most frequently implicated CH gene, whereas other CH subtypes were rare and genetically heterogeneous. Cases reported as DI involved seven genes, most commonly LRRK2 – PRKN and PINK1 – PRKN , although most variant combinations were unique. Across the CH and reported-DI groups, patients presented with a core Parkinsonian syndrome but showed substantial variability in age at onset, motor severity, and non-motor manifestations. PRKN -associated CH cases generally had earlier onset and favorable levodopa responsiveness, whereas PLA2G6 - and VPS13C -associated cases more often exhibited cognitive impairment, psychiatric features, or structural neuroimaging abnormalities. No reproducible genotype-specific phenotype emerged. Compound heterozygous represents a conventional biallelic recessive mechanism in EOPD and was largely driven by PRKN structural variation. In contrast, cases reported as DI were rare and heterogeneous, and the available evidence generally did not establish causal digenic inheritance. These findings support comprehensive detection of structural and sequence variants while highlighting the need for segregation, functional, and replication evidence to distinguish causal DI from modifier effects or coincidental variant co-occurrence.

Read PDF

Similar papers

Open access Sep 2026

Genetic Screening of Colombian Patients With Early-Onset Parkinson Disease

This study helps characterize genetic contributors to EOPD in Colombian patients, demonstrating genetic forms (PRKN, PINK1, and DJ-1) are rare.

Tobias M. Franz, Marios Gavrielatos, Ysabella Wijaya et al. · 0 citations
Case report Open access Sep 2026

A Heterozygous Variant in the GABBR2 Gene in a Girl With Clinical Classic Rett Syndrome

Findings support a role for GABBR2‐mediated GABAergic signaling in the pathophysiology of RTT and highlight the importance of considering GABBR2 in the genetic evaluation of MECP2‐negative patients with a clinical RTT phenotype.

Jenny Klintenstedt, P. Baeck, I. Engerström et al. · 0 citations
Open access Sep 2026

Comprehensive assessment of the genotype-phenotype spectrum and treatment for monoallelic insulin receptoropathy in a cohort of 505 people

Background: Insulin signalling is mediated by the INSR-encoded receptor tyrosine kinase. Biallelic INSR variants cause the most severe insulin resistance (IR), whereas heterozygous mutations cause less rare but still severe IR. Dominantly inherited IR has been attributed to dominant negative action of intracellular (IC...

Rebecca J. Brown, Jing-Xiang Xu, J. Luan et al. · 0 citations
Oct 2026

Clinical and genetic heterogeneity of Triple A syndrome: a multicenter study.

Triple A syndrome (AAAS) is a rare autosomal recessive neuroendocrine disorder caused by pathogenic variants in the AAAS gene and characterized by marked clinical heterogeneity. In this multicenter retrospective study, we analyzed 23 patients from 18 families diagnosed across nine centers in Türkiye to characterize the...

Dilek Çelebi, Aslıhan Kiraz, Zakhiriddin Khojakulov et al. · 0 citations
Open access Oct 2026

Non-Coding Structural Variants in Regulatory Regions and High Polygenic Burden May Jointly Contribute to Early-Onset Familial Hashimoto’s Thyroiditis

Background/Objectives: Multigenerational families with unusually early disease onset provide a unique opportunity to investigate the genetic architecture underlying the missing heritability of complex diseases. Here, we investigated the genetic basis of apparent autosomal dominant early-onset Hashimoto’s thyroiditis (H...

Vesna Boraska Perica, Ana Barić Žižić, S. Sladic et al. · 0 citations
Case report Open access Jan 2026

Biallelic WDR19 Variants: Systematic Analysis of Genotype–Phenotype Correlations

Genotype–phenotype analyses indicated that the presence of a truncating variant was associated with increased likelihood of skeletal involvement and reduced likelihood of hepatobiliary disease compared with individuals harbouring only missense variants, and variants located outside repeat protein domains were associate...

Zoe Webster, Lisa Woods, R. Dalziel et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.